FierceHealthcare
Industry Voices—A Look at DOJ Fraud Enforcement Efforts in the Medicare Advantage Space
May 20, 2019
The Department of Justice’s enforcement focus on the healthcare industry has been consistently intense over the last 20 years, though the specific areas of scrutiny shift and evolve. In this article, Jaime Jones and Jennifer Haney of Sidley’s Healthcare practice examine DOJ fraud enforcement efforts relating to Medicare Advantage.
Related Blogs
Capabilities
Suggested News & Insights
EU Pharma Package: Sharp New Tools With Limited ProtectionsDecember 18, 2025First Chair Trial and Leading Product Liability Lawyer Paul Boehm Joins Sidley as Partner in D.C. to Expand Product Liability and Mass Torts Litigation PracticeDecember 18, 2025EU Biotech Act: EU Proposes First Set of Rules to Facilitate Biopharmaceutical CompetitivenessThursday, December 18, 2025Sidley Represents Changchun GeneScience (GenSci) Pharmaceuticals in Its Strategic Licensing Agreement With Yarrow Bioscience for First-in-Class Autoimmune Thyroid Disease TherapyDecember 18, 2025Sidley Secures Plan Confirmation in Prospect Medical Holdings' US$2.3 Billion Chapter 11 CaseDecember 17, 2025Sidley Represents Apollo Funds in Majority Investment in Prosol GroupDecember 16, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory